Clinical Trial

Diagnostic Accuracy of Eus Fnb in Difficult to Reach Lesions

Completed
View on ClinicalTrials.gov →
Summary
The present study aims at comprehensively assessing the diagnostic performance and safety profile of EUS-FNB as a primary diagnostic tool for suspected malignancies in anatomically complex or deeply situated regions, including the duodeno-jejunal, and hepatic hilar areas. By focusing on lesions that are challenging to reach due to their intricate anatomy or profound depth, investigators seek to provide valuable insights into the potential role of EUS-FNB in enhancing diagnostic accuracy and safety in these complex clinical scenarios.
Trial Details
NCT Number NCT07621536
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Hilar Cholangiocarcinoma, Duodenal Neoplasms
Enrollment 131 participants
Start Date 2025-10-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-02